Tetanus News and Research

RSS

Tetanus is a severe, frequently fatal disease caused by an exotoxin produced by Clostridium tetani, a bacterium that is found in the environment. Tetanus is not transmitted from person to person. Rather, Clostridium tetani enters the body through an open wound, including lacerations, abrasions and puncture wounds. The toxin causes neuromuscular dysfunction, with rigidity and spasms of skeletal muscles. The muscle spasms usually start in the jaw (which is why the disease is sometimes called "lockjaw") and neck and may spread to many other muscles, leading to generalized paralysis.

Gardasil reaction report released

The National Vaccine Information Center (NVIC) today released a new analysis of the federal Vaccine Adverse Event Reporting System (VAERS) reports of serious health problems following HPV vaccination (Merck's Gardasil) during the last six months of 2006.

21 Feb 2007

GAVI Alliance brings immunisation rates to record highs in poor countries

New data from the World Health Organization (WHO) show that the GAVI Alliance, a groundbreaking global initiative to increase access to children's vaccines, has brought immunisation rates to record highs in poor countries.

28 Jan 2007

Link between common lifestyle factors, immune system and cancer

The immune system is fickle, and easily influenced by more than just viruses and bacteria. It can be swayed by the seemingly unexpected, such as by what we eat, for example, and affected by surprising sources.

13 Nov 2006

Racial gap in childhood vaccination rate closes

The overall vaccination rate among black children ages 19 months to 35 months last year for the first time equaled rates among white, Asian and Hispanic children in the same age group, according to a CDC report released recently, the AP/Seattle Post-Intelligencer reports.

18 Sep 2006

Needle-less immunisation is coming

Those of us who are squeamish about having an injection can take a sigh of relief: needle-less immunisation is coming our way according to new research revealed today at the British Pharmaceutical Conference in Manchester.

4 Sep 2006

$1.5 billion needed to cover years supply of pediatric vaccines

A six-month stockpile of recommended pediatric vaccines would cost $1 billion and could cover more than 90 percent of U.S. children during a six-month interruption in production, say researchers at two Illinois universities.

19 Apr 2006

First evidence that dendritic cells show unprecedented sensitivity to thimerosal

A team of cell biologists, toxicologists and molecular bioscientists at UC Davis has published a study connecting thimerosal with disruptions in antigen-presenting cells known as dendritic cells obtained from mice.

22 Mar 2006

Reaction to DTaP vaccine finds no help from ibuprofen, acetaminophen

A red splotch forms where most preschoolers get their fifth, and last, shot of the acellular diphtheria-tetanus-pertussis (DTaP) vaccine, and it can last a few days.

1 Mar 2006

Vaccine against ricin safe and effective

Scientists at the University of Texas Southwestern Medical Center at Dallas, say a vaccine against the deadly toxin ricin is safe and effective.

31 Jan 2006

Proper home care can assist would healing

A slip with a kitchen knife, a spill off a bike or a fall on the sidewalk. It’s not uncommon to have a mishap that breaks the skin. When a wound occurs, your body quickly begins regeneration and repair. You can facilitate healing with proper home care.

29 Dec 2005

New whooping cough vaccine for adolescents and adults

In the first study of its kind, researchers at Saint Louis University have demonstrated that immunization with a new vaccine could potentially prevent more than a million cases of pertussis (whooping cough) each year in adolescents and adults.

24 Oct 2005

Whooping cough vaccine 90 percent effective

A vaccine to protect adults and adolescents against illness due to Bordetella pertussis infection--or whooping cough--has proved more than 90 percent effective in a national, large-scale clinical study, according to research results published in this week's issue of The New England Journal of Medicine.

12 Oct 2005

Vaccine against group B streptococcus

Common bacteria that live harmlessly in the gastrointestinal tract and vagina of 25 percent of women can become lethal if a newborn gets exposed to them during birth.

20 Sep 2005

Retinoic acid combined with PIC, a synthetic immunity booster, significantly elevates the immune system response to a tetanus shot

These results show that a natural product of vitamin A can have an important role in regulating immunity and, when administered along with PIC, might be a potentially powerful nutritional-immunological assist in vaccination."

12 Sep 2005

No link between multiple vaccinations and infections

Over the years many concerns have been raised about chilhood vacinations, and one concern has been that multiple vaccinations 'use up' the immune system, so children are unable to fight off other illnesses.

10 Aug 2005

Findings do not support the hypothesis of increased risk of nontargeted infectious disease hospitalization after childhood vaccination

New research does not support a belief that children receiving multiple vaccines increase their risk of hospitalization for a nontargeted infectious disease, according to a study in the August 10 issue of JAMA: The Journal of the American Medical Association.

9 Aug 2005

Steady upward climb in child vaccinations

According to U.S. health officials, a record high rate of 81 percent of toddlers 19 months to 3 years old are now getting vaccinated with the full recommended series.

27 Jul 2005

America's Children: Key National Indicators of Well-Being 2005

The adolescent birth rate has reached another record low, the death rate for children between ages 1 and 4 is the lowest ever, young children are more likely to receive their recommended immunizations, and fourth graders are scoring better in math, according to a yearly compendium of statistics from federal agencies concerned with children.

20 Jul 2005

Tetanus toxin may help fight depression, anxiety, anorexia and Parkinson's

A team of researchers from the Department of Biochemistry and Molecular Biology and the Institute of Neuroscience at the Universitat Autònoma de Barcelona has discovered that tetanus toxin, which causes tetanus, could be extremely useful as a therapy against psychological disorders such as depression, anxiety and anorexia, and to slow the progress of neurodegenerative disorders such as Parkinson's disease.

14 Jun 2005

FDA approves whooping cough vaccine for adults

The U.S. Food and Drug Administration (FDA) has given drug company Sanofi-Aventis approval to sell Adacel, a vaccine against whooping cough for people ages 11 to 64.

12 Jun 2005